Therapeutic treatment for Allergen-induced asthma and Allergic Rhinitis: 1α,25-dihydroxyvitamin D(3) suppresses the expression of Interleukin-13 (IL-13) via up regulation of its target gene, 18/January/2014, 6.51 am

Therapeutic treatment for Allergen-induced asthma and Allergic Rhinitis: 1α,25-dihydroxyvitamin D(3) suppresses the expression of Interleukin-13 (IL-13) via up regulation of its target gene, 18/January/2014, 6.51 am

Therapeutic treatment for Allergen-induced asthma and Allergic Rhinitis: 1α,25-dihydroxyvitamin D(3) suppresses the expression of Interleukin-13 (IL-13) via up regulation of its target gene, 18/January/2014, 6.51 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Therapeutic treatment for Allergen-induced asthma and Allergic Rhinitis: 1α,25-dihydroxyvitamin D(3) suppresses the expression of Interleukin-13 (IL-13) via up regulation of its target gene, 18/January/2014, 6.51 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing